These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2830814)

  • 1. Combinations of rifampin or rifabutine plus ethambutol against Mycobacterium avium complex. Bactericidal synergistic, and bacteriostatic additive or synergistic effects.
    Heifets LB; Iseman MD; Lindholm-Levy PJ
    Am Rev Respir Dis; 1988 Mar; 137(3):711-5. PubMed ID: 2830814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Iseman MD
    Am Rev Respir Dis; 1988 Mar; 137(3):719-21. PubMed ID: 2830815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Flory MA
    Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi].
    Gevaudan MJ; Mallet MN; Bollet C; Gulian C; de Micco P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):585-90. PubMed ID: 2552379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
    Woodley CL; Kilburn JO
    Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
    Truffot-Pernot C; Giroir AM; Maury L; Grosset J
    Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activities of rifabutine and rifampicin against Mycobacterium avium complex infections in mice and in peritoneal macrophages].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):173-9. PubMed ID: 2836650
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
    Zimmer BL; DeYoung DR; Roberts GD
    Antimicrob Agents Chemother; 1982 Jul; 22(1):148-50. PubMed ID: 7125626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intra-macrophagic activity of antibiotics combinations against Mycobacterium marinum].
    Gevaudan MJ; Bollet C; Mallet MN; de Micco P
    Pathol Biol (Paris); 1991 May; 39(5):436-41. PubMed ID: 1652732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex.
    Rastogi N; Labrousse V
    Antimicrob Agents Chemother; 1991 Mar; 35(3):462-70. PubMed ID: 1828135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of macrolides used in combination with ethambutol, with or without other drugs, against Mycobacterium avium within human macrophages.
    Schiavano GF; Celeste AG; Salvaggio L; Sisti M; Brandi G
    Int J Antimicrob Agents; 2001 Dec; 18(6):525-30. PubMed ID: 11738339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.
    Hoffner SE; Svenson SB; Källenius G
    Eur J Clin Microbiol; 1987 Oct; 6(5):530-5. PubMed ID: 3436314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro and in vivo activity of rifabutin and rifampicin against Mycobacterium avium complex.
    Saito H; Sato K; Tomioka H
    Tubercle; 1988 Sep; 69(3):187-92. PubMed ID: 2855458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome.
    Baron EJ; Young LS
    Diagn Microbiol Infect Dis; 1986 Sep; 5(3):215-20. PubMed ID: 3757474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
    Dickinson JM; Mitchison DA
    Tubercle; 1987 Sep; 68(3):177-82. PubMed ID: 2834842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro testing of clarithromycin in combination with ethambutol and rifampicin against Mycobacterium avium complex.
    Stauffer F; Dörtbudak O; Lahonik E
    Infection; 1991; 19(5):343-5. PubMed ID: 1839300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
    Nash DR; Steingrube VA
    Microbios; 1982; 35(140):71-8. PubMed ID: 7162431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.